Being in early adulthood does not mean you’re immune to arthritis. Dr Etienne Masle-Farquhar challenges the myth that arthritis only affects the elderly, sharing Kevin’s experience with psoriatic arthritis and his own journey with spondyloarthritis. https://ow.ly/ry7P50YnPNK

Help make everyday moments easier for people living with arthritis. Your support will help to shape a future where people with arthritis get the right treatment sooner and spend less time in pain. 👉 Donate to accelerate discovery: https://ow.ly/7Q7z50YlHkj #Arthritis #MedicalResearch

Curious about arthritis research? Join Dr Etienne Masle-Farquhar, in person or online, to discover how his team is shaping a future where people with arthritis can live with less pain. Learn more: https://ow.ly/S4nE50YlH9K #Arthritis #ArthritisResearch #MedicalResearch #Seminar #Events

Walking. Tying a shoelace. Cooking. For 1 in 7 Australians with arthritis, pain makes these everyday moments challenging. Dr Etienne Masle-Farquhar’s research aims to improve treatment outcomes and shape the future of arthritis care. https://ow.ly/uBrp50YkPbw

Do you have a World Major Marathon on your bucket list? Sign up to #Go4Garvan at the Sydney Marathon 2026 and support life-changing medical research. Learn more: https://ow.ly/a72c50Yk4rP

Join Dr Etienne Masle-Farquhar at Garvan or online to learn how his team are using cutting-edge methods to better understand arthritis — with the aim of developing better treatments for this debilitating condition. Learn more: https://ow.ly/SKhI50YhoAB #arthritis #medicalresearch

Ever wondered what it takes to make a medical breakthrough? Join a public tour to learn about our history, the bright minds behind our breakthroughs, and how research translates from the lab to the community. Learn more: https://ow.ly/ZrsN50YeKAG

Announcing the appointment of Dr Clare Puttick to Garvan Faculty. 🧬 A computational biologist, Dr Puttick will establish a new lab focused on understanding how lung and breast cancers hide from the body's natural defences. Read more about her work here: https://ow.ly/7I7q50YeNCz

To close our International Day of Women and Girls in Science series, we spoke with Dr Amanda Khoury, Senior Research Officer in Garvan’s Clark Lab. Amanda shared what inspired her to pursue science and what continues to excite her about her work. #WomenInScience #WomenInSTEMM

Next up in our series to mark yesterday's International Day of Women and Girls in Science,we feature Professor Marina Pajic, a leader in pancreatic cancer research at Garvan. We asked Marina why she pursued a career in science and what excites her about her work today.

It’s the International Day of Women and Girls in Science. Today, we celebrate the achievements of women and girls in STEMM and reaffirm our commitment to advancing equal access, participation and leadership in science. #womeninscience #unitednations #womenandgirlsinscience

Second in our Women and Girls in Science series: Dr Cerys McCool, who recently completed her PhD at Garvan. We asked Cerys what drew her to science and what she’s most proud of.

11th February is the International Day of Women and Girls in Science. Ahead of the day, we’re spotlighting some of the women at Garvan and the discoveries they make possible. We begin this series with Dr Rachel Galimidi.

Global collaboration in action: Dr Brooke Pereira represented Garvan in California at the Empowering Women in Cancer Research Preceptorship, a joint initiative between the ACRF and Amgen. This leadership program allowed Dr Pereira to showcase work from our ACRF INCITe Centre.

The reveal is here. That mysterious box we teased on Monday? It’s the Illumina NovaSeq X, now installed at Garvan. A major boost for our genomics research and critical infrastructure for our TenK10K project. Services available from mid 2026. https://ow.ly/Yeg850Y5eOS

Associate Professor David Croucher explains neuroblastoma, a childhood cancer with a high mortality rate if it returns. Garvan researchers have identified a combination of existing drugs that may bypass the cancer’s natural defence mechanisms. Read more: https://ow.ly/viSK50Y8wOU

In this episode of Medical Minds, we hear from Dr Rachel Galimidi who is at the forefront of biologics drug development and is working to make new and better treatments for a range of diseases. Listen to the full episode on Apple or Spotify.

February is ovarian cancer awareness month. A/Prof Liz Caldon, who leads ovarian cancer research at Garvan, explains what ovarian cancer is, the impact it has on women in Australia, and how our scientists are working to improve treatment outcomes. https://ow.ly/fHZ950Y7mSW

Something big has arrived at Garvan. 📦 A new technology that will transform how we study single cells and speed up critical research. Any guesses? Full reveal Friday.

Explore new opportunities at Garvan. We are recruiting a research assistant with expertise in stem cell biology (particularly iPSCs) to support research within our iPSC Village platform. Learn more or apply at https://ow.ly/YpRc50Y44jm

In this episode, Dr Ankur Sharma delves into the critical insight that cancer is not just a rogue cell – it’s an entire ecosystem – and that ecosystem is the key to unlocking a new class of cures. Listen here: https://ow.ly/NWGN50Y44tv

Pick your challenge. Go4Garvan. Power life-changing medical research. Find out how you can Go4Garvan here: bit.ly/Go4Garvan

Associate Professor David Croucher is investigating high-risk neuroblastoma – an aggressive childhood cancer. His team is developing new approaches to overcome drug resistance. Find out more: https://ow.ly/mZBU50Y1tYQ

Exciting news: Garvan’s Prof Marina Pajic has been awarded MRFF funding to lead a team undertaking two trials testing new approaches for pancreatic cancer. Read more: https://ow.ly/t4eW50Y0Z5F

An international team, co-led by Garvan's Prof Stuart Tangye, has discovered that the protein CBL is crucial for B cell development, shedding light on immune function and why some people are more prone to infections. Published today in Nature Immunology: ow.ly/gk4z50XX0Y7

📖 The December issue of Breakthrough Magazine is now live on our website. In this edition, discover the AI tool revolutionising our understanding of cancer cell behaviour, explore how immunity is being engineered to fight disease and more. Click here: ow.ly/6fsG50XB2w5

A Garvan-led trial showed metformin doesn’t lower insulin resistance in type 1 diabetes but does reduce insulin needs. Here, Dr Jennifer Snaith explains what insulin resistance is and why managing blood glucose levels matters. Read more: ow.ly/mJxV50Xyuq5

A Garvan-led trial reveals that metformin – an affordable type 2 diabetes drug – can reduce insulin needs in type 1 diabetes. While it doesn’t counteract insulin resistance, it helps maintain ideal blood sugars with less insulin. This could improve how doctors manage the condition.

This #WorldPancreaticCancerDay, PanKind is funding two new projects at Garvan. These projects address why pancreatic cancer is so deadly: its ability to resist treatment and hide until it’s too late.

Bev has lived most of her life in a body she doesn’t fully understand. After decades of unexplained symptoms, she is still searching for answers. To read Bev’s story, click here: www.garvan.org.au/impact/stori...

Huge congratulations to the following Garvan researchers who have received funding through the 2026 St Vincent’s Clinic Research Foundation Grants. Dr Seyhan Yazar, A/Prof David Croucher, Dr Zoe Phan and Dr Ashraf Zaman. Your research is having a transformative impact on health.

🔬 New insights into breast cancer treatment resistance. Garvan researchers have uncovered how a broken JNK pathway allows some ER+ breast cancers to resist standard therapies. 👉 Find out more: ow.ly/NKk650Xaj9h #BreastCancerResearch #CancerBreakthrough #PersonalisedMedicine

📊 How do we know if a cancer drug will work? It starts with choosing the right lab test. Newly published Garvan research compared different lab testing methods for PARP inhibitors – important drugs for people with cancers caused by BRCA mutations

Do older people want to know their genetic disease risk? 🧬 Garvan researchers found participants aged 70+ valued this information – mainly for the benefit of their children & grandchildren. Read more: ow.ly/9zBc50X44wC

Last month we announced that Garvan was awarded the inaugural Collaborative Research Accelerator (CRA) grant from the National Breast Cancer Foundation (NBCF) for its AllClear program, led by Garvan’s Associate Professor Christine Chaffer and Professor Peter Croucher.

🧬 A recent Garvan-led study (GENIE) is recruiting Australian children and adults to help improve the early detection of genetic conditions that affect the immune system. Read more about the study here: ow.ly/f7Gp50WVy6x

Congratulations to Dr Hasindu Gamaarachchi, awarded the 2025 #EurekaPrizes for Outstanding Early Career Researcher! He is developing computational methods to dramatically cut time and power needed to analyse genomic sequencing data, with huge ramifications for medical research. ow.ly/Uc9c50WQTro

When Michael first started experiencing pain in his lower back, he put it down to a cricket injury. At 48, he was active and healthy, with no reason to suspect something worse. Then a scan revealed the unthinkable. Read Michael's story here: ow.ly/qOsI50WrAyE

Did you know? Garvan and Yale University researchers paired up to develop a new AI tool that could be integrated into cancer diagnostics to better inform treatment. Find out more: ow.ly/jzU550WlpRT

Garvan Institute & Yale researchers have created AAnet, a powerful AI tool that studies individual cells within cancer tumours, opening the door to more targeted therapies. #AI #CancerResearch

Today our lab head Prof Marina Pajic, along with Prof Anthony Joshua and PurpleOurWorld’s Daniel Goulburn OAM delivered an inspiring public seminar today at @garvaninstitute.bsky.social on how we are working to improve outcomes for patients with #PancreaticCancer.

Hear from one of our wonderful volunteers and supporters, Annie, who has committed to decades of giving back. Read her story here: ow.ly/mvXO50WetTF

Congratulations to Garvan researcher Shanon Ranjit, who last week won the Early-Stage Innovation Forum pitch as part of the AusMedtech conference. Shanon is part of the team leading Garvan's Genomics Platform. Find out more: ow.ly/2FXJ50W3P5n

Huge congrats to Prof Daniel MacArthur on receiving the prestigious ESHG award for his outstanding work in human genetics. He leads the Centre for Population Genomics, a joint initiative of Garvan & @MCRI_for_kids #ESHG2025 Read more: ow.ly/p8vi50W3Oee

Sydney researchers are recruiting for a study aimed at improving diagnosis, treatment and support for an estimated two million people who live with rare genetic diseases in Australia alone. Click here to find out more: ow.ly/2IN350VLKqx

Why does the arm you choose for a vaccine matter? 🩹 New research from Garvan and the Kirby Institute shows that receiving a booster in the same arm as the initial dose can lead to a quicker, stronger immune response. ow.ly/HbA150VJmWl

Did you miss our recent seminar? Watch Garvan researchers and collaborators share insights on transforming inflammatory bowel disease diagnosis and treatment approaches in this informative session. Click here: ow.ly/5OkU50Vx6Ki

Thinking about the future and the legacy you want to leave behind? Garvan has partnered with Gathered Here to help you prepare your Will for free. Click the link below to write your Will – it only takes 10 mins! ow.ly/cOJF50VvrWU

Carrier screening helps identify if prospective parents carry genetic variants that could affect their children’s health. But how many genes should be tested to make screening both effective and equitable? @miagruzin.bsky.social

Today Team Pajic Lab proudly walked in the #PanKindAus #PutYourFootDown #Sydney to raise awareness for #PancreaticCancer. We raised over $1300 for pancreatic cancer research and enjoyed the morning hugely. Thank you @garvaninstitute.bsky.social for the outfits!